JP2018506562A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506562A5
JP2018506562A5 JP2017545269A JP2017545269A JP2018506562A5 JP 2018506562 A5 JP2018506562 A5 JP 2018506562A5 JP 2017545269 A JP2017545269 A JP 2017545269A JP 2017545269 A JP2017545269 A JP 2017545269A JP 2018506562 A5 JP2018506562 A5 JP 2018506562A5
Authority
JP
Japan
Prior art keywords
aminopiperidin
pyrrolo
pyridin
bromo
cyclopropanecarboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017545269A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018506562A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/019904 external-priority patent/WO2016138458A1/en
Publication of JP2018506562A publication Critical patent/JP2018506562A/ja
Publication of JP2018506562A5 publication Critical patent/JP2018506562A5/ja
Withdrawn legal-status Critical Current

Links

JP2017545269A 2015-02-26 2016-02-26 ピロロピリジン化合物の結晶形態 Withdrawn JP2018506562A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26
US62/121,396 2015-02-26
PCT/US2016/019904 WO2016138458A1 (en) 2015-02-26 2016-02-26 Crystalline forms of a pyrrolopyridine compound

Publications (2)

Publication Number Publication Date
JP2018506562A JP2018506562A (ja) 2018-03-08
JP2018506562A5 true JP2018506562A5 (cg-RX-API-DMAC10.html) 2019-03-28

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017545269A Withdrawn JP2018506562A (ja) 2015-02-26 2016-02-26 ピロロピリジン化合物の結晶形態

Country Status (21)

Country Link
US (2) US20160251350A1 (cg-RX-API-DMAC10.html)
EP (1) EP3262042A1 (cg-RX-API-DMAC10.html)
JP (1) JP2018506562A (cg-RX-API-DMAC10.html)
KR (1) KR20170118762A (cg-RX-API-DMAC10.html)
CN (1) CN107406447A (cg-RX-API-DMAC10.html)
AR (1) AR103801A1 (cg-RX-API-DMAC10.html)
AU (1) AU2016225070A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017018230A2 (cg-RX-API-DMAC10.html)
CA (1) CA2976665A1 (cg-RX-API-DMAC10.html)
CL (1) CL2017002180A1 (cg-RX-API-DMAC10.html)
CO (1) CO2017009662A2 (cg-RX-API-DMAC10.html)
CR (1) CR20170439A (cg-RX-API-DMAC10.html)
HK (1) HK1246786A1 (cg-RX-API-DMAC10.html)
IL (1) IL254115A0 (cg-RX-API-DMAC10.html)
MA (1) MA41599A (cg-RX-API-DMAC10.html)
MX (1) MX2017010888A (cg-RX-API-DMAC10.html)
PE (1) PE20171327A1 (cg-RX-API-DMAC10.html)
PH (1) PH12017501532A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017133093A (cg-RX-API-DMAC10.html)
SG (1) SG11201706824TA (cg-RX-API-DMAC10.html)
WO (1) WO2016138458A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102405199B1 (ko) * 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
US12559463B2 (en) 2019-02-12 2026-02-24 Impact Biomedicines Inc. Crystalline forms of a JAK2 inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
CN108721284A (zh) * 2010-11-16 2018-11-02 阵列生物制药公司 检测点激酶1抑制剂和wee1激酶抑制剂的组合
CA2921956C (en) * 2013-08-22 2021-10-19 Genentech, Inc. Process for preparing (r)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1h-pyrrolo[2,3-b]pyridine
WO2015027090A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Intermediates and processes for preparing compounds

Similar Documents

Publication Publication Date Title
JP2022058395A5 (cg-RX-API-DMAC10.html)
KR101668931B1 (ko) 항종양제의 효과 증강제
ES2911040T3 (es) Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2)
JP2017537946A5 (cg-RX-API-DMAC10.html)
JP2016513704A5 (cg-RX-API-DMAC10.html)
JP2008528466A5 (cg-RX-API-DMAC10.html)
CN110582483A (zh) 含邻氨基杂芳环炔基的化合物及其制备方法和用途
JP2017510643A5 (cg-RX-API-DMAC10.html)
CN107163027B (zh) 吡啶胺基嘧啶衍生物甲磺酸盐的结晶形式及其制备和应用
WO2001083456A1 (en) Condensed heteroaryl derivatives
JP2015512942A5 (cg-RX-API-DMAC10.html)
JP2015536986A (ja) 併用療法
AU2018226922B2 (en) Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof
BR112017003312B1 (pt) Compostos de indazol como inibidores de fgfr quinase, preparação e uso dos mesmos
JP2014518544A5 (cg-RX-API-DMAC10.html)
CN104854091A (zh) 含砜基团的5-氟-n-(吡啶-2-基)吡啶-2-胺衍生物
JP2014532751A5 (cg-RX-API-DMAC10.html)
JP2016525104A5 (cg-RX-API-DMAC10.html)
WO2013170758A1 (zh) 含稠环结构的苯甲酰胺类化合物及其作为抗肿瘤药物应用
WO2017118401A1 (zh) 喹啉衍生物用于治疗食管癌的用途及其治疗方法、药物组合物和试剂盒
CN101686970A (zh) 邻氨基苯甲酰胺吡啶脲及苯甲酰胺衍生物的协同组合
JP2016502540A5 (cg-RX-API-DMAC10.html)
RU2017133093A (ru) Кристаллические формы соединения пирролопиридина
JP2022526525A5 (cg-RX-API-DMAC10.html)
JP2014521730A5 (cg-RX-API-DMAC10.html)